Filing Details

Accession Number:
0001209191-14-039020
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-04 17:01:34
Reporting Period:
2014-05-23
Filing Date:
2014-06-04
Accepted Time:
2014-06-04 17:01:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1438869 D Paul Arata 3280 Bayshore Blvd
Brisbane CA 94005
Evp, Human Resources & Admin No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-23 10,000 $8.05 32,795 No 4 M Direct
Common Stock Disposition 2014-05-23 10,000 $40.00 22,795 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock options (right to buy) Disposition 2014-05-23 10,000 $0.00 10,000 $8.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
52,500 2019-08-07 No 4 M Direct
Footnotes
  1. The transaction was made pursuant to the terms of the 10b5-1 plan in effect at the time of the transaction.
  2. Fully exercisable.